Indivior Pharmaceuticals, Inc. · NASDAQ:INDV
Stejbach Mark received 6,518 Indivior Pharmaceuticals, Inc. shares as an award (Form 4)
Traded May 13, 2026 · Filed May 14, 2026
On May 13, 2026, Stejbach Mark (Director) received 6,518 Indivior Pharmaceuticals, Inc. shares as an award, leaving 27,087 shares. Filed May 14, 2026 (Form 4).
- Awarded
- 6,518 shares
- Holding after
- 27,087 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 13, 2026 | Common Stock | Award | 6,518 | 27,087 | Direct |
Source
Related
- Indivior Pharmaceuticals, Inc.
- Stejbach Mark
- Indivior Pharmaceuticals, Inc. shareholders
- Schedule 13G · Millennium Management LLC · Sep 30, 2026
- Form 4 · Anderson Woodrow D · Aug 27, 2026
- Schedule 13D/A · Oaktree Capital Holdings, LLC · Aug 13, 2026
- Form 4 · Anderson Woodrow D · Aug 5, 2026
- Form 4 · Heidbreder Christian · Jul 13, 2026